A Study to Evaluate Corrected QT Interval From Clinical Studies Conducted With Bevacizumab

This study has been withdrawn prior to enrollment.
Sponsor:
Information provided by:
Genentech
ClinicalTrials.gov Identifier:
NCT00477425
First received: May 21, 2007
Last updated: December 1, 2010
Last verified: December 2010

May 21, 2007
December 1, 2010
June 2007
Not Provided
Not Provided
Not Provided
Complete list of historical versions of study NCT00477425 on ClinicalTrials.gov Archive Site
Not Provided
Not Provided
Not Provided
Not Provided
 
A Study to Evaluate Corrected QT Interval From Clinical Studies Conducted With Bevacizumab
Evaluation of Corrected QT Interval From Clinical Studies Conducted With Bevacizumab

This is a supplemental study designed to evaluate the effect of bevacizumab on QTc interval in cancer patients. Patients who have consented to participate in selected randomized controlled bevacizumab clinical trials will be invited to participate in this study.

Not Provided
Observational
Time Perspective: Prospective
Not Provided
Not Provided
Not Provided
Not Provided
Carcinoma
Not Provided
Not Provided
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Withdrawn
150
Not Provided
Not Provided

Inclusion Criteria:

  • Signed Informed Consent Form
  • Enrollment in one of a list of certain randomized, controlled bevacizumab trials

Exclusion Criteria:

  • Implantable pacemaker or automatic implantable cardioverter defibrillator (AICD)
  • Congenital long QT syndrome
  • Family history of long QT syndrome
  • Clinically significant bradycardia (defined as < 50 beats/minute)
Both
Not Provided
No
Contact information is only displayed when the study is recruiting subjects
Not Provided
 
NCT00477425
AVF4223g
Not Provided
Not Provided
Genentech
Not Provided
Study Director: Jane Huang, M.D. Genentech
Genentech
December 2010

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP